Screener
Corvus Pharmaceuticals CRVS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
FAQ
- What is Corvus Pharmaceuticals's current ratio?
- Corvus Pharmaceuticals (CRVS) reported current ratio of 19.8× in Q1 2026.
- How has Corvus Pharmaceuticals's current ratio changed year-over-year?
- Corvus Pharmaceuticals's current ratio increased by 304.2% year-over-year, from 4.9× to 19.8×.
- What is the long-term trend for Corvus Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's current ratio has grown at a 10.7% compound annual growth rate (CAGR), from 3.7× to 6.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Corvus Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude